PDUFA 6 Could Make Breakthrough Status More Routine, Hamburg Says
Executive Summary
FDA commissioner tells PhRMA that for next round of the user fee program, “we are really going to have to figure out how to take advantage of the insight that this early, continuing engagement really matters.”